Comparison of paclitaxel in combination with cisplatin (TP), carboplatin (TC) or fluorouracil (TF) concurrent with radiotherapy for patients with local advanced oesophageal squamous cell carcinoma: a three-arm phase III randomized trial (ESO-Shanghai 2)

INTRODUCTION: Concurrent chemoradiation is the standard therapy for patients with local advanced oesophageal carcinoma unsuitable for surgery. Paclitaxel is an active agent against oesophageal cancer and it has been proved as a potent radiation sensitiser. There have been multiple studies evaluating...

Descripción completa

Detalles Bibliográficos
Autores principales: Ai, Dashan, Chen, Yun, Liu, Qi, Zhang, Junhua, Deng, Jiaying, Zhu, Hanting, Ren, Wenjia, Zheng, Xiangpeng, Li, Yunhai, Wei, Shihong, Ye, Jinjun, Zhou, Jialiang, Lin, Qin, Luo, Hui, Cao, Jianzhong, Li, Jiancheng, Huang, Guang, Wu, Kailiang, Fan, Min, Yang, Huanjun, Zhu, Zhengfei, Zhao, Weixin, Li, Ling, Fan, Jianhong, Badakhshi, Harun, Zhao, Kuaile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196866/
https://www.ncbi.nlm.nih.gov/pubmed/30344165
http://dx.doi.org/10.1136/bmjopen-2017-020785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196866/
https://www.ncbi.nlm.nih.gov/pubmed/30344165
http://dx.doi.org/10.1136/bmjopen-2017-020785

Ejemplares similares